diabetes of type2. Non-insulin dependent diabetes mellitus
Conditions
Interventions
Intervention 1: The intervention group receive three capsules daily, each containing 350 mg of rich Oligosaccharides fraction taken from Rosa arvensis which is added to the standard treatment and in c
Treatment - Drugs
The intervention group receive three capsules daily, each containing 350 mg of rich Oligosaccharides fraction taken from Rosa arvensis which is added to the standard treatment and in case of decreasin
Control group receive treatment with a common protocol.
Sponsors
Barekat Pharmaceutical Company
Eligibility
Sex/Gender
All
Age
1 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: diabetes diagnosis with fasting blood sugar over 125, or postprandial glucose over 200 or glycosylated hemoglobin level greater than 6; patient willingness and signed informed consent, age less than 65 years; history of diabetes less than 10 years; diabetes onset at least three months before. Exclusion criteria: requiring insulin injections or diagnosis of type 1 diabetes, kidney disease, liver disease, cancer, anemia and heart failure, pregnancy, glycosylated hemoglobin over 10, corticosteroids use.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood sugar (FBS). Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test.;Glucose tolerance test (BS). Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test.;Hba1c rate. Timepoint: Baseline, 3 and 6 months after starting the study. Method of measurement: Test. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed